Report Finds Market-Based Solutions to Boost Biosimilar Competition and Hold Drug Companies Accountable Would Lower Prices And Increase Innovation For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday reacting to a new study from Avik Roy and Gregg Girvan of the…
Brand Name Drug Maker AstraZeneca Aggressively Raised Prices In The Middle Of A Pandemic, Even While Receiving Hundreds Of Millions In Taxpayer Funding Vaccine Maker Got $1 Billion From Taxpayers.
Report Finds Just Five Instances Of Product Hopping Sticks Americans With $4.7 Billion Price Tag In case you missed it, a new study by Alex Brill of Matrix Global Advisors (MGA), commissioned by the…
Tweet Misstates Impact of Misguided Rebate Rule That Would Do Nothing to Lower Drug Prices, While Increasing Medicare Premiums For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]
Study Finds Rebates Negotiated By PBMs Reduce Rx Costs and Lower Premiums – Eliminating Rebates Would Increase Costs On American Seniors & Taxpayers, While Handing Big Pharma a Bailout In case…
U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of Blockbuster Cancer, Immunosuppressant Drugs Will Help Hold Industry Accountable For Immediate Release Contact: Jon Conradi…
Administration Should Shelve Rebate Rule That Would Increase Medicare Premiums, Cost Taxpayers $200 Billion and Hand Big Pharma a Massive Bailout In case you missed it, a new poll first reported by…
Tracking Data Finds Drug Companies Increased Prices On at Least 67 Brand Name Drugs This Summer Despite Economic Crisis and Rising Concern With Rx Affordability For Immediate Release Contact: Jon…
White House Should Reject Pharma-Backed Policies That Would Hand Drug Companies a Windfall on the Backs of American Taxpayers For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]
Misguided Measure Would Increase Medicare Part D Premiums, Cost Taxpayers More Than $200 Billion and Do Nothing To Lower Prescription Drug Prices On Monday, the Trump Administration released a list…